A randomized phase II non-comparative study of PF-04691502 and gedatolisib (PF-05212384) in patients with recurrent endometrial cancer

1. Del Campo, J.M.
2. Birrer, M.
3. Davis, C.
4. Fujiwara, K.
5. Gollerkeri, A.
6. Gore, M.
7. Houk, B.
8. Lau, S.
9. Poveda, A.
10. González-Martín, A.
11. Muller, C.
12. Muro, K.
13. Pierce, K.
14. Suzuki, M.
15. Vermette, J.
16. Oza, A.